Physician profile
Helen Le
NPI 1669995916
$1,929.83
in general payments reported to CMS, 2019-2025
17 companies · $24.21 in 2025
The $24.21 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $58.66 · 2021: $19.83 · 2022: $291 · 2023: $761 · 2024: $538 · 2025: $24.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $550.25 | 2022-2024 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $428.76 | 2022-2024 | Cequa |
| Bausch & Lomb Americas INC. | $318.65 | 2022-2024 | Vyzulta, Xiidra, Miebo |
| Alcon Vision LLC | $134.06 | 2022-2024 | Rocklatan, Simbrinza |
| Allergan, INC. | $125.11 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $76.92 | 2019 | |
| Novartis Pharmaceuticals Corporation | $53.00 | 2022-2023 | |
| Aerie Pharmaceuticals, INC. | $42.90 | 2020-2021 | |
| Shire North American Group INC | $40.70 | 2019 | |
| Abbvie INC. | $34.11 | 2024 | |
| Rxsight INC | $24.21 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Rayner Intraocular Lenses Limited | $21.93 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Visioneering Technologies, INC. | $18.12 | 2022 | |
| Coopervision INC. | $16.08 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spark Therapeutics, INC. | $14.72 | 2022 | |
| Kala Pharmaceuticals, INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.